Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|June 10, 2025
Discovery of KDX1381, a Bivalent CK2α Inhibitor for the Treatment of Solid Tumors as a Single Agent or in CombinationLéna Marlhoux, Alexandre Arnaud, Céline Hervieu, et al.
Journal of Medicinal Chemistry|September 20, 2024
Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar ActivitySebastian Mielniczuk, Katharina Hoff, Fady Baselious, et al.
Nature Communications|September 23, 2016
Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activitiesAbdelhakim Ahmed-Belkacem, Lionel Colliandre, Nazim Ahnou, et al.
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.
Cancer Research|January 2, 2009
Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant functionCarla E Cano, Julien Gommeaux, Sylvia Pietri, et al.
European Journal of Medicinal Chemistry|June 7, 2025
Picomolar bivalent inhibitors of protein kinase CK2 active against β-coronavirus replicationDylan Grenier, Dennis Salomon Lopez Molina, Muriel Gelin, et al.
The FEBS Journal|October 5, 2022
Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosisSarah Barelier, Romain Avellan, Giri Raj Gnawali, et al.
Angewandte Chemie (International Ed. in English)|April 17, 2015
A combination of spin diffusion methods for the determination of protein-ligand complex structural ensemblesJens Pilger, Adam Mazur, Peter Monecke, et al.
Pageof 7